| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Liminal BioSciences Inc (F: PJ2N)
PJ2N Technical Analysis
5
| As on 2nd Feb 2023 PJ2N STOCK Price closed @ 4.62 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.81 & Strong Buy for SHORT-TERM with Stoploss of 1.72 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PJ2NSTOCK Price
| Open | 4.59 | Change | Price | % |
| High | 4.67 | 1 Day | 0.82 | 21.58 |
| Low | 4.59 | 1 Week | 4.24 | 1115.79 |
| Close | 4.62 | 1 Month | 4.54 | 5675.00 |
| Volume | 60 | 1 Year | 2.84 | 159.55 |
| 52 Week High 2.30 | 52 Week Low 0.01 | ||||
F Germany Most Active Stocks
| ENB | 47.60 | -0.92% |
| TEF | 3.84 | -0.52% |
| TEF | 3.84 | -0.52% |
| WHL | 5150.00 | -0.44% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| TOE | 0.02 | 0.00% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
| PJ2N Daily Charts |
PJ2N Intraday Charts |
Whats New @ Bazaartrend |
PJ2N Free Analysis |
|
|
PJ2N Important Levels Intraday
| RESISTANCE | 4.77 |
| RESISTANCE | 4.72 |
| RESISTANCE | 4.69 |
| RESISTANCE | 4.66 |
| SUPPORT | 4.58 |
| SUPPORT | 4.55 |
| SUPPORT | 4.52 |
| SUPPORT | 4.47 |
PJ2N Forecast May 2024
| 4th UP Forecast | 6.45 |
| 3rd UP Forecast | 5.86 |
| 2nd UP Forecast | 5.5 |
| 1st UP Forecast | 5.14 |
| 1st DOWN Forecast | 4.1 |
| 2nd DOWN Forecast | 3.74 |
| 3rd DOWN Forecast | 3.38 |
| 4th DOWN Forecast | 2.79 |
PJ2N Weekly Forecast
| 4th UP Forecast | 5.58 |
| 3rd UP Forecast | 5.27 |
| 2nd UP Forecast | 5.08 |
| 1st UP Forecast | 4.89 |
| 1st DOWN Forecast | 4.35 |
| 2nd DOWN Forecast | 4.16 |
| 3rd DOWN Forecast | 3.97 |
| 4th DOWN Forecast | 3.66 |
PJ2N Forecast2024
| 4th UP Forecast | 13.6 |
| 3rd UP Forecast | 10.72 |
| 2nd UP Forecast | 8.94 |
| 1st UP Forecast | 7.16 |
| 1st DOWN Forecast | 2.08 |
| 2nd DOWN Forecast | 0.3 |
| 3rd DOWN Forecast | -1.48 |
| 4th DOWN Forecast | -4.36 |
Liminal BioSciences Inc ( F Germany Symbol : PJ2N )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PJ2N Business Profile
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on discovery, development, and commercialization of novel small molecule drug candidates for the treatment of patients suffering from respiratory fibrotic diseases and other fibrotic or inflammatory diseases that have high unmet medical needs. It operates through two segments, Small Molecule Therapeutics and Plasma-Derived Therapeutics. The Small Molecule Therapeutics segment's lead product candidate is fezagepras (PBI-4050), which is in Phase 1 for the treatment of idiopathic pulmonary fibrosis and respiratory diseases. The Plasma-Derived Therapeutics segment focused on the development of its plasma-derived product candidate Ryplazim, a purified glu-plasminogen derived from human plasma that acts as a plasminogen replacement therapy for patients deficient in plasminogen protein. The company operates in Canada, the United Kingdom, and the United States. The company was formerly known as Prometic Life Sciences Inc. and changed its name to Liminal BioSciences Inc. in October 2019. Liminal BioSciences Inc. was incorporated in 1994 and is headquartered in Laval, Canada. Address: 440 Boulevard Armand-Frappier, Laval, QC, Canada, H7V 4B4
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service